Study: ADT tied to higher A1C levels in men with diabetes

03/6/2013 | MedWire News (U.K.)

Male diabetes patients who underwent androgen deprivation therapy for prostate cancer showed higher A1C at two years compared with those who did not receive ADT, a study found. "Men with diabetes who start ADT should be counseled about the potential need for intensification of diabetes therapy and should have their [A1C] levels monitored during therapy, especially if they continue on long-term ADT," researchers wrote in the journal European Urology.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA